Poster Abstracts
Grand Hall CD (Manchester Grand Hyatt)
Immunological Effects of Decidual Stromal Cell Treatment in Patients with Severe Chronic Graft-Versus-Host Disease
Tom Erkers, MSc, Karolinska Institutet;
Helen Kaipe, PhD, Karolinska Institutet;
Silvia Nava, BSc, Karolinska Institutet;
Pia Molldén, BSc, Karolinska Institutet;
Britt Gustafsson, Huddinge University Hospital;
Rimma Axelsson, MD, PhD, Karolinska University Hospital;
Olle Ringden, MD, PhD, Karolinska Institutet
Increased Collection Efficiency of Spectra OPTIA Reduces the Blood Volume Processed to Acquire Targeted CD34+ Dose
Cheryl Gottsacker, Cancer Treatment Centers of America @ Midwestern Regional Medical Center;
Adetola Akinwande, Cancer Treatment Centers of America @ Midwestern Regional Medical Center;
Tamara Loos, PhD, Terumo BCT;
Monika Payne, Cancer Treatment Centers of America @ Midwestern Regional Medical Center;
Syed A. Abutalib, MD, Cancer Treatment Centers of America @ Midwestern Regional Medical Center;
Bradford Tan, MD, Cancer Treatment Centers of America @ Midwestern Regional Medical Center
Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Lymphoma Post Allogeneic STEM CELL Transplant
Serena Kimi Perna, MD, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Stephen Gottschalk, MD, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Vicky Torrano, BS, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Oumar Diouf, BS, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Renuka P Miller, PhD, Children’s National Medical Center;
George Carrum, MD, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Carlos A. Ramos, MD, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Hao Liu, Baylor College of Medicine;
Men-Feng Wu, Baylor College of Medicine;
Robert A. Krance, MD, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Kathryn Leung, MD, Baylor College of Medicine, Texas Children's Hospital;
Adrian P. Gee, PhD, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Cliona M. Rooney, PhD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital;
Malcolm K. Brenner, MD, PhD, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Helen E. Heslop, MD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital;
Catherine M. Bollard, MD, Children's National Medical Center
Placenta-Derived Decidual Stromal Cells for Graft-Versus-Host Disease, Hemorrhaging, and Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation
Olle Ringden, MD, PhD, Karolinska Institutet;
Martin Solders, MD, Karolinska Institutet;
Tom Erkers, MSc, Karolinska Institutet;
Silvia Nava, BSc, Karolinska Institutet;
Pia Molldén, BSc, Karolinska Institutet;
Bita Khoein, Karolinska Institutet;
Arjang Baygan, Karolinska Institutet;
Wictor Aronsson-Kurttila, Karolinska Institutet;
Salimullah Mohmand, Karolinska Institutet;
Mats Remberger, PhD, Karolinska University Hospital;
Magnus Westgren, MD, PhD, Karolinska Institutet;
Jonas Mattsson, MD PhD, Karolinska University Hospital;
Behnam Sadeghi, MD PhD, Karolinska Institutet;
Helen Kaipe, PhD, Karolinska Institutet
Establishment of a Highly Characterized Third-Party Virus-Specific T Lymphocyte Bank for Treatment of EBV+ Lymphoma
Rayne Helen Rouce, M.D., Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital;
Serena K. Perna, M.D., Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital;
Gayatri Vyas, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital;
Sandhya Sharma, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital;
Manasa Hiregange, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital;
Natalia Lapteva, PhD, Baylor College of Medicine/Center for Cell and Gene Therapy;
Ann M. Leen, PhD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital;
Helen E. Heslop, MD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital;
Ifigenia Tzannou, MD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital;
Carlos Ramos, MD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital;
Cliona M. Rooney, PhD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital
Treatment of Secondary Graft Failure after Hematopoietic Stem Cell Transplantation with Alpha/Beta T-Cell Depleted Grafts As Booster Infusions
Emelie Rĺdestad, Karolinska Institutet;
Helena Wikell, Karolinska University Hospital;
Mats Engström, MD, Karolinska University Hospital;
Emma Watz, MD, Karolinska Institutet;
Berit Sundberg, Karolinska University Hospital;
Sarah Thunberg, PhD, Karolinska University Hospital;
Mehmet Uzunel, PhD, Karolinska University Hospital;
Jonas Mattsson, MD PhD, Karolinska University Hospital;
Michael Uhlin, PhD, Karolinska University Hospital
NOVEL Strategy to Enhance NK CELL Activity
Reshmi Parameswaran, Case Western Reserve University;
Basem M. William, MD, MRCP(UK), University Hospitals Seidman Cancer Center and Case Western Reserve University;
Stephen Moreton, Case Western Reserve University;
Dean Lee, MD, PhD, University of Texas MD Anderson Cancer Center;
Paramaeswaran Ramakrishnan, Case Western Reserve University;
Marcos J. G. de Lima, MD, University Hospitals Seidman Cancer Center and Case Western Reserve University;
David Wald, Case Western Reserve University
Spinal Cord Injection of Stem Cells for Pediatric ALS
Laura L Worth, MD, PhD, University of Texas MD Anderson Cancer Center;
John Mark Slopis, MD, MPH, M D Anderson Cancer Center;
Mary Kay Koenig, MD, University of TX Health Science Center at Houston;
Richard E. Champlin, MD, The University of Texas MD Anderson Cancer Center;
Ian E McCutcheon, MD, M D Anderson Cancer Center